I agree..........ENTB is a crap of a stock/company (best thing is to get rid of this partly owned subsidiary of BMSN). The run is because of Regen BioPharma (a wholly subsidiary of BMSN) and is probably the only good thing Koos did in his 5 years was purchasing this company in mid 2012 (whether it was experience or luck, who knows), using the 41M 'asset' of cause.